Welcome to the international HTA database

Showing [23371 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	HAYES, Inc.	Testosterone for low sexual desire in nonsurgically postmenopausal women
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Inspire® Upper Airway Stimulation System for obstructive sleep apnoea
2013	HAYES, Inc.	Nanoparticle albumin-bound paclitaxel for non-small cell lung cancer
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Whole exome sequencing for patients with intellectual disability/mental retardation or ASD]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficiency of peritoneal dialysis versus hemodialysis for the treatment of renal insufficiency]
2013	HAYES, Inc.	Transradial, transbrachial, and transulnar approaches for coronary angiography and intervention
2013	HAYES, Inc.	Angiotensin receptor 1 (AGTR1) c.*86A>C (1166A>C, A1166C) polymorphism testing for essential hypertension
2013	HAYES, Inc.	Neuroform microdelivery stent system for intracranial aneurysms
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Laparoscopic vertical sleeve gastrectomy vs. laparoscopic Roux-en Y gastric bypass for the treatment of obesity]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Efficacy and efficiency of psychological, psychiatric, sociomedical and complementary medical interventions for excessive crying in primary care services ("Schreiambulanzen") ]
2013	HAYES, Inc.	BRAF p.Val600Glu (V600E) testing to predict response to vemurafenib in malignant melanoma
2013	HAYES, Inc.	Pneumatic compression for prevention of deep vein thrombosis following knee surgery
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Tocilizumab for the treatment of rheumatoid arthritis]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Esteem® totally implantable hearing device for treatment of sensorineural hearing loss. Systematic review]
2013	NIHR Health Technology Assessment programme	Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review
2013	HAYES, Inc.	CHEK2-related susceptibility to breast cancer
2013	HAYES, Inc.	Roux-en-Y gastric bypass for gastroesophageal reflux disease in obese or severely obese patients
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Temozolomide for anaplastic oligodendroglioma]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for biotinidase deficiency]
2013	HAYES, Inc.	Citrin deficiency
2013	HAYES, Inc.	Salivary hormone testing for menopausal women
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thiopurine-methyltransferase genotyping prior to thiopurine therapy]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of the Solitaire® flow restoration blood device]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for congenital adrenal hyperplasia]
2013	HAYES, Inc.	Cystic Fibrosis Transmembrane Regulator (CFTR) testing for cystic fibrosis
2013	HAYES, Inc.	Spinal cord stimulation for relief of neuropathic pain
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Chromosomal microarrays for the etiologic diagnosis in patients with intellectual disability, developmental delay or autism spectrum]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Safety of natural therapies with direct impact on health: Acupuncture]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for classical galactosemia]
2013	HAYES, Inc.	DNA Polymerase Gamma (POLG)-related disorders
2013	HAYES, Inc.	Autosomal Dominant Hereditary Spastic Paraplegia (AD-HSP)
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Risk-reducing surgery in BRCA1 or 2 mutation carriers]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy, effectivity and efficiency of liquid cytology for cervical cancer screening and HPV infection diagnosis]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for tyrosemia type I]
2013	NIHR Health Technology Assessment programme	Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation
2013	HAYES, Inc.	Ehlers-Danlos Syndrome type IV (EDS IV)
2013	HAYES, Inc.	Autosomal Recessive Hereditary Spastic Paraplegia (AR-HSP)
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Use of antibiotic-loaded bone cement in primary hip and knee arthroplasty]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness of patient self-testing and patient self-management of oral anticoagulation with vitamin K antagonists]
2013	Canary Health Service	[Effectiveness and safety of biodegradable tracheobronchial prostheses]
2013	HAYES, Inc.	BRAF p.Val600Glu testing in papillary thyroid carcinoma
2013	HAYES, Inc.	Genomic microarray analysis for intellectual disability, developmental delay, multiple congenital anomalies, and autism spectrum disorders
2013	HAYES, Inc.	Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC)
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Brentuximab vedotin for Hodgkin´s lymphoma]
2013	Canary Health Service	[Deep brain stimulation in neurological and psychiatric disorders]
2013	NIHR Health Technology Assessment programme	A systematic review and cost-effectiveness analysis of specialist services and adrenaline auto-injectors in anaphylaxis
2013	HAYES, Inc.	Ehlers-danlos syndrome (EDS), classic type
2013	HAYES, Inc.	Janus kinase 2 (JAK2) p.Val617Phe testing for myeloproliferative neoplasms
2013	HAYES, Inc.	Myeloproliferative Leukemia virus oncogene (MPL) testing in Myeloproliferative Neoplasms (MPNs)
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Miglustat for patients with niemann-pick disease type C]
2013	Canary Health Service	[Manual with evaluation and validation criteria for shared decision-making tools]
2013	HAYES, Inc.	Familial mediterranean fever (FMF)
2013	HAYES, Inc.	Stickler syndrome (arthro-ophthalmopathy)
2013	HAYES, Inc.	Noninvasive Prenatal Testing (NIPT) for fetal aneuploidy
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Drug-eluting stents in coronary heart disease]
2013	Health Quality Ontario (HQO)	Electrocardiograms for diagnosing ischemia as a precipitant to acute heart failure: a rapid review
2013	Canary Health Service	[Cost-effectiveness review of physiotherapy interventions in knee osteoarthritis]
2013	HAYES, Inc.	Interleukin 28B (IL28B) testing to predict response to treatment of hepatitis C virus (HCV) infection
2013	HAYES, Inc.	Administration of pegfilgrastim (Neulasta; Amgen Inc.) on the same day as chemotherapy
2013	HAYES, Inc.	Whole exome sequencing for cancer indications
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ultrasensitive C-reactive protein as a prognostic biomarker for cardiovascular disease]
2013	Health Quality Ontario (HQO)	Relationship of patient volume and stroke outcomes: a rapid review
2013	Canary Health Service	[Endobronchial valves: effectiveness, safety, and cost-effectiveness]
2013	HAYES, Inc.	Kabuki syndrome
2013	HAYES, Inc.	Computed Tomography (CT)-guided lung biopsy with the superDimension i-Logic System (Covidien)
2013	HAYES, Inc.	Whole exome sequencing for noncancer indications
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Digital tomosynthesis for the diagnosis of breast cancer]
2013	Health Quality Ontario (HQO)	Action plans for individuals with chronic obstructive pulmonary disease (COPD): a rapid review
2013	Canary Health Service	[Cost-effectiveness analysis of microarrays for prenatal diagnosis of genetic aberrations in Spain]
2013	NIHR Health Technology Assessment programme	Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation
2013	HAYES, Inc.	PreOvar KRAS-variant test for ovarian cancer
2013	HAYES, Inc.	Disinfection caps with isopropyl alcohol-impregnated sponges for needleless connectors to reduce central line-associated bloodstream infections
2013	HAYES, Inc.	Oncotype DX colon cancer assay
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[MRI enterography for the assessment of inflammatory bowel disease]
2013	Health Quality Ontario (HQO)	Inhospital physiotherapy for acute exacerbations of chronic obstructive pulmonary disease (AECOPD): a rapid review
2013	Canary Health Service	[Cost-effectiveness of electroconvulsive therapy in the treatment of depression. Systematic review and economic evaluation]
2013	HAYES, Inc.	C-leg prostheses (Otto Bock HealthCare LP) for patients with above-knee amputation
2013	HAYES, Inc.	Endoloop ligature (Ethicon Endo-Surgery Inc.) for appendiceal stump closure during laparoscopic appendectomy
2013	HAYES, Inc.	Acupuncture for treatment of Chronic Obstructive Pulmonary Disease (COPD)
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Denosumab versus bisphosphonates for the treatment of osteoporosis in post-menopausal women]
2013	Health Quality Ontario (HQO)	B-type natriuretic peptide testing: a rapid review
2013	NIHR Health Technology Assessment programme	Systematic review of the psychological consequences of false-positive screening mammograms
2013	HAYES, Inc.	Coflex interlaminar stabilization device (Paradigm Spine LLC) for treatment of lumbar spinal stenosis
2013	HAYES, Inc.	Humira (Adalimumab; Abbott Laboratories) for treatment of pediatric crohn's disease
2013	HAYES, Inc.	In-hospital patient bathing with 2% chlorhexidine gluconate cloths (Sage Products Inc.) for prevention of hospital-acquired infections
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Actualization: radiofrequency sympathetic denervation of the renal arteries for refractory arterial hypertension]
2013	Health Quality Ontario (HQO)	Chest X-rays for diagnosing pulmonary infection as a precipitant of acute heart failure: a rapid review
2012	NIHR Horizon Scanning Centre (NIHR HSC)	CT-P13 (Infliximab biosimilar) for rheumatoid arthritis
2012	Finnish Office for Health Care Technology Assessment (Finohta)	[Continuous subcutaneous insulin infusion in type 1 diabetes mellitus]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Rilonacept for gout
2012	Canary Health Service	[Effectiveness and cost-effectiveness of different pertussis immunization strategies to reduce infant morbidity and mortality]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Tocilizumab (RoActemra) for active polyarticular juvenile idiopathic arthritis – second line
2012	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Fingolimod - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2012	Canary Health Service	[Effectiveness and cost-effectiveness of determining abeta-42, total tau, and phosphorylated tau proteins in cerebrospinal fluid as biomarkers for Alzheimer's disease]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Pitolisant for hypersomnia and narcolepsy in patients with Parkinson's disease
2012	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cabazitaxel - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2012	Canary Health Service	[Efficacy and cost-effectiveness of cardiac rehabilitation in patients with ischemic heart disease in the outpatient setting (update)]
2012	NIHR Health Technology Assessment programme	Exercise interventions for the management of health related quality of life and fatigue in cancer survivors during and after treatment
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Davunetide intranasal for progressive supranuclear palsy – first line